Table 5 Comparison of clinical and biochemistry parameters at baseline and 1-year follow-up in MetS patients
Variables | Pre-intervention (n = 151) | Post-intervention (n = 151) | P value |
|---|---|---|---|
MetS score | 3.68 ± 0.70 | 3.17 ± 0.98 |  < 0.001 |
Wt (kg) | 77.90 ± 11.86 | 73.37 ± 12.30 |  < 0.001 |
BMI (kg/m2) | 29.25 ± 3.24 | 27.77 ± 3.44 |  < 0.001 |
WC (cm) | |||
 Male | 99.07 ± 7.28 | 95.68 ± 8.01 |  < 0.001 |
 Female | 89.25 ± 7.05 | 87.86 ± 7.15 | 0.048 |
SBP (mmHg) | 141.83 ± 16.05 | 138.60 ± 17.36 | 0.017 |
DBP (mmHg) | 90.61 ± 9.08 | 89.89 ± 11.23 | 0.405 |
TC (mmol/L) | 4.91 (4.30, 5.73) | 4.93 (4.37, 5.65) | 0.445 |
TG (mmol/L) | 1.80 (1.31, 2.45) | 1.66 (1.14, 2.28) | 0.241 |
HDL-C (mmol/L) | |||
 Male | 1.04 (0.89, 1.15) | 1.01 (0.89, 1.14) | 0.636 |
 Female | 1.18 (1.03, 1.29) | 1.15 (1.07, 1.35) | 0.352 |
LDL-C (mmol/L) | 3.05 ± 0.74 | 3.20 ± 0.73 | 0.007 |
FBG (mmol/L) | 5.56 ± 0.55 | 5.27 ± 0.61 | 0.008 |
UA | 271.25 ± 83.00 | 278.19 ± 74.62 | 0.068 |
VAI | |||
 Male | 2.56 (1.97, 3.76) | 2.52 (1.78, 3.29) | 0.315 |
 Female | 2.64 (1.90, 3.73) | 2.05 (1.48, 3.35) | 0.790 |
LAP | |||
 Male | 67.33 (49.59, 90.90) | 55.68 (39.12, 82.32) | 0.054 |
 Female | 52.92 (38.16, 65.92) | 40.83 (29.23, 62.34) | 0.361 |
TyG | 9.00 ± 0.52 | 8.83 ± 0.58 |  < 0.001 |
MetS-IR | 45.59 (41.16, 50.23) | 42.69 (38.94, 48.20) |  < 0.001 |
TG/HDL-C | 1.72 (1.12, 2.27) | 1.50 (0.91, 2.16) | 0.324 |
25(OH)D (ng/mL) | 14.13 ± 3.65 | 16.00 ± 4.09 |  < 0.001 |
PTH (mmol/L) | 43.1 (36.68. 52.63) | 37.35 (27.60, 50.17) |  < 0.001 |